Juliano Laura M, Griffiths Roland R
Department of Psychology, American University, 4400 Massachusetts Avenue, Washington, DC 20016, USA.
Psychopharmacology (Berl). 2004 Oct;176(1):1-29. doi: 10.1007/s00213-004-2000-x. Epub 2004 Sep 21.
Although reports of caffeine withdrawal in the medical literature date back more than 170 years, the most rigorous experimental investigations of the phenomenon have been conducted only recently.
The purpose of this paper is to provide a comprehensive review and analysis of the literature regarding human caffeine withdrawal to empirically validate specific symptoms and signs, and to appraise important features of the syndrome.
A literature search identified 57 experimental and 9 survey studies on caffeine withdrawal that met inclusion criteria. The methodological features of each study were examined to assess the validity of the effects.
Of 49 symptom categories identified, the following 10 fulfilled validity criteria: headache, fatigue, decreased energy/activeness, decreased alertness, drowsiness, decreased contentedness, depressed mood, difficulty concentrating, irritability, and foggy/not clearheaded. In addition, flu-like symptoms, nausea/vomiting, and muscle pain/stiffness were judged likely to represent valid symptom categories. In experimental studies, the incidence of headache was 50% and the incidence of clinically significant distress or functional impairment was 13%. Typically, onset of symptoms occurred 12-24 h after abstinence, with peak intensity at 20-51 h, and for a duration of 2-9 days. In general, the incidence or severity of symptoms increased with increases in daily dose; abstinence from doses as low as 100 mg/day produced symptoms. Research is reviewed indicating that expectancies are not a prime determinant of caffeine withdrawal and that avoidance of withdrawal symptoms plays a central role in habitual caffeine consumption.
The caffeine-withdrawal syndrome has been well characterized and there is sufficient empirical evidence to warrant inclusion of caffeine withdrawal as a disorder in the DSM and revision of diagnostic criteria in the ICD.
尽管医学文献中关于咖啡因戒断的报道可追溯到170多年前,但对这一现象最严格的实验研究直到最近才开展。
本文旨在对有关人类咖啡因戒断的文献进行全面综述和分析,以实证验证特定的症状和体征,并评估该综合征的重要特征。
通过文献检索,确定了57项符合纳入标准的关于咖啡因戒断的实验研究和9项调查研究。对每项研究的方法学特征进行了审查,以评估其效果的有效性。
在确定的49个症状类别中,以下10个符合有效性标准:头痛、疲劳、精力/活跃度下降、警觉性降低、嗜睡、满足感降低、情绪低落、注意力难以集中、易怒、头脑不清醒。此外,类似流感的症状、恶心/呕吐以及肌肉疼痛/僵硬被判定可能代表有效的症状类别。在实验研究中,头痛的发生率为50%,具有临床意义的痛苦或功能损害的发生率为13%。症状通常在戒断后12 - 24小时出现,在20 - 51小时达到峰值强度,持续2 - 9天。一般来说,症状的发生率或严重程度随着每日剂量的增加而增加;即使从低至100毫克/天的剂量戒断也会产生症状。所综述的研究表明,预期并非咖啡因戒断的主要决定因素,而避免戒断症状在习惯性咖啡因消费中起核心作用。
咖啡因戒断综合征已得到充分描述,有足够的实证证据支持将咖啡因戒断作为一种疾病纳入《精神疾病诊断与统计手册》(DSM)并修订《国际疾病分类》(ICD)中的诊断标准。